1TAIEB A, PICARDO M, VETF MEMBERS. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force [ J ]. Pigment Cell Res, 2007,20 ( 1 ) :27 - 35.
2LE POOLE I C, DAS P K, VAN DEN WIJNGAARD R M, et al. Review of the etiopathomechanism of vitiligo : a convergence theory [ J ]. Exp Dermatol, 1993,2 (4) : 146 - 153.
4ELASSIUTY YE,KLARQUIST J,SPEISER J,et al. Heme oxygen- ase - 1 expression protects melanocytes from stress - induced cell death: implications for vitiligo[ M]. Exp Dermatnl,2011,20(6) : 496 - 501.
5DELL'ANNA M L, MARESCA V, BRIGANTI S, et al. Mito- chondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo [ J ]. J Invest Dermatol,2001,117 (4) : 908 -913.
6MARESCA V, ROCCELLA M, ROCCELLA F. Increased sensi- tivity to perexidative agents as a possible pathogenic factor of mela- nocyte damage in vitiligo [ J ]. J Invest Dermatol, 1997,109 ( 3 ) : 310 -313.
7SCHALLREUTER K U, WOOD J M, BERGER J. et al. Low cat- alase levels in the epidermis of patients with vitiligo[ J]. J Invest Dermatol, 1991,97 (6) : 1081 - 1085.
8SRAVANI P V, BABU N K, GOPAL K V T,et al. Herpes zoster motor neuropathy: a clinical and eleetrophysiological study [ J ]. In- dian J Dermatol Venereol Leprol,2009,75(5 ):268 -271.
9SALEM M M, SHALBAF M, GIBBONS N C J, et al. Enhanced DNA binding capacity on up - regulated epidermal wild - type p53 in vitiligo by HE 02 - mediated oxidation : a possible repair mecha- nism for DNA damage[ J]. FASEB J ,2009,23 ( 11 ) :3790 - 3807.
10GIOVANNELLI L, BELLAND1 S, PITOZZI V, et al. Increased oxidative DNA damage in mononuclear leukocytes in vitiligo [ J ]. Mutat Res,2004,556( 1 -2) :101 - 106.
二级参考文献25
1Liu J, Man W, Lv CZ, et al. Epidermal Permeability Barrier Recovery Is Delayed in Vitiligo Involved Sites [ J ]. Skin Pharmacol Physiol,2010, 23(4) : 193 -200.
2Elassiuty YE, Klarquist J, Speiser J, et al. Heme oxygenase-1 expression protects melanocytes from stress-induced cell death : implications for vitiligo [ J ]. Exp Dermatol, 2011,20 (6) :496 - 501.
3Jain A, Mal J, Mehndiratta V, et al. Study of oxidative stress in vitiligo [ J ]. Indian J Clin Biochem, 2011,26( 1 ) :78 - 81.
4Jalel A, Hamdaoui MH. Study of total antioxidant status and glutathione peroxidase activity in Tunisian vitiligo patients [ J ]. Indian J Dermatol, 2009, 54 ( 1 ) : 13 -16.
5Scharschmidt TC, Man MQ, HatanoY, et al. Filaggrin deficiericy confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens[ J ]. J Allergy Clin Immunol, 2009, 124(3 ) :496 - 506.
6Cho HR, Uhm YK, Kim H J, et al. Glutathione S-transferase M1 ( GSTM1 ) poly- morphism is associated with atopic dermatitis susceptibility in a Korean population [J]. Int J Immunogenet,2011, 38(2): 145 - 150.
7Sapuntsova SG, Lebed' ko OA, Shchetkina MV, et al. Status of free-radical oxidation and proliferation processes in patients with atopic dermatitis and lichen planus [J]. Bull Exp Biol Med, 2011,150(6) : 690 - 692.
8Vermeij WP, Alia A, Backendorf C. ROS quenching potential of the epidermal cornifled cell envelope[ J]. J Invest Dermatol, 2011, 131(7) :1435 -1441.
9Kharaeva Z, Gostova E, De Luca C, et al. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients [ J ]. Nutrition ,2009, 25 ( 3 ) :295 - 302.
10Hseu YC, Chou CW, Senthil Kumar KJ, E11agic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregnlation of the HO-1 and Nrf-2 antioxidant genes [ J ]. Food Chem Toxicol, 2012, 50(5) :1245 - 1255.
